<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39308818</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>14</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2167-8359</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>PeerJ</Title><ISOAbbreviation>PeerJ</ISOAbbreviation></Journal><ArticleTitle>Bacterial co-infection in COVID-19: a call to stay vigilant.</ArticleTitle><Pagination><StartPage>e18041</StartPage><MedlinePgn>e18041</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e18041</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7717/peerj.18041</ELocationID><Abstract><AbstractText>Co-infection with diverse bacteria is commonly seen in patients infected with the novel coronavirus, SARS-CoV-2. This type of co-infection significantly impacts the occurrence and development of novel coronavirus infection. Bacterial co-pathogens are typically identified in the respiratory system and blood culture, which complicates the diagnosis, treatment, and prognosis of COVID-19, and even exacerbates the severity of disease symptoms and increases mortality rates. However, the status and impact of bacterial co-infections during the COVID-19 pandemic have not been properly studied. Recently, the amount of literature on the co-infection of SARS-CoV-2 and bacteria has gradually increased, enabling a comprehensive discussion on this type of co-infection. In this study, we focus on bacterial infections in the respiratory system and blood of patients with COVID-19 because these infection types significantly affect the severity and mortality of COVID-19. Furthermore, the progression of COVID-19 has markedly elevated the antimicrobial resistance among specific bacteria, such as <i>Klebsiella pneumoniae</i>, in clinical settings including intensive care units (ICUs). Grasping these resistance patterns is pivotal for the optimal utilization and stewardship of antibiotics, including fluoroquinolones. Our study offers insights into these aspects and serves as a fundamental basis for devising effective therapeutic strategies. We primarily sourced our articles from PubMed, ScienceDirect, Scopus, and Google Scholar. We queried these databases using specific search terms related to COVID-19 and its co-infections with bacteria or fungi, and selectively chose relevant articles for inclusion in our review.</AbstractText><CopyrightInformation>© 2024 Liu et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Shengbi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Guiqian International General Hospital, Guiyang, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Chao</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-0589-8986</Identifier><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Guiqian International General Hospital, Guiyang, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tu</LastName><ForeName>Qin</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Guiqian International General Hospital, Guiyang, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Qianming</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Guiqian International General Hospital, Guiyang, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fu</LastName><ForeName>Zuowei</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Guiqian International General Hospital, Guiyang, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Yifeng</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Guiqian International General Hospital, Guiyang, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Chuan</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Guiqian International General Hospital, Guiyang, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Guiqian International General Hospital, Guiyang, People's Republic of China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PeerJ</MedlineTA><NlmUniqueID>101603425</NlmUniqueID><ISSNLinking>2167-8359</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060085" MajorTopicYN="Y">Coinfection</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001424" MajorTopicYN="Y">Bacterial Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D024881" MajorTopicYN="N">Drug Resistance, Bacterial</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Antimicrobial resistance</Keyword><Keyword MajorTopicYN="N">Bloodstream infection</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Co-infection</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Ventilator-associated pneumonia</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>11</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>11</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>5</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39308818</ArticleId><ArticleId IdType="pmc">PMC11416760</ArticleId><ArticleId IdType="doi">10.7717/peerj.18041</ArticleId><ArticleId IdType="pii">18041</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abelenda-Alonso G, Rombauts A, Gudiol C, Oriol I, Simonetti A, Coloma A, Rodríguez-Molinero A, Izquierdo E, Díaz-Brito V, Sanmartí M, Padullés A, Grau I, Ras M, Bergas A, Guillem L, Blanco-Arévalo A, Alvarez-Pouso C, Pallarés N, Videla S, Tebé C, Carratalà J. Immunomodulatory therapy, risk factors and outcomes of hospital-acquired bloodstream infection in patients with severe COVID-19 pneumonia: a Spanish case-control matched multicentre study (BACTCOVID) Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. 2021;27(11):1685–1692. doi: 10.1016/j.cmi.2021.06.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.06.041</ArticleId><ArticleId IdType="pmc">PMC8260492</ArticleId><ArticleId IdType="pubmed">34242804</ArticleId></ArticleIdList></Reference><Reference><Citation>AlAhdal AM, Alsada SA, Alrashed HA, Al Bazroun LI, Alshoaibi A. Impact of the COVID-19 pandemic on levels of device-associated infections and hand hygiene compliance. Curēus. 2022;14(4):e24254. doi: 10.7759/cureus.24254.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.24254</ArticleId><ArticleId IdType="pmc">PMC9020414</ArticleId><ArticleId IdType="pubmed">35475245</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrianopoulos I, Maniatopoulou T, Lagos N, Kazakos N, Papathanasiou A, Papathanakos G, Koulenti D, Kittas C, Koulouras V. Acinetobacter baumannii bloodstream infections in the COVID-19 era: a comparative analysis between COVID-19 and non-COVID-19 critically ill patients. Microorganisms. 2023;11(7):1811. doi: 10.3390/microorganisms11071811.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms11071811</ArticleId><ArticleId IdType="pmc">PMC10383443</ArticleId><ArticleId IdType="pubmed">37512983</ArticleId></ArticleIdList></Reference><Reference><Citation>Antimicrobial Resistance Collaborators Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629–655. doi: 10.1016/S0140-6736(21)02724-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)02724-0</ArticleId><ArticleId IdType="pmc">PMC8841637</ArticleId><ArticleId IdType="pubmed">35065702</ArticleId></ArticleIdList></Reference><Reference><Citation>Aslan AT, Tabah A, Köylü B, Kalem AK, Aksoy F, Erol Ç, Karaali R, Tunay B, Guzeldağ S, Batirel A, Dindar EK, Akdoğan Ö, Bilir Y, Ersöz G, Öztürk B, Selçuk M, Yilmaz M, Akyol A, Akbaş T, Sungurtekin H, Timuroğlu A, Gürbüz Y, Çolak O, Bayindir Y, Eroğlu A, Ferlicolak L, Çeşme U, Dağ O, Buetti N, Barbier F, Ruckly S, Staiquly Q, Timsit JF, Akova M. Epidemiology and risk factors of 28-day mortality of hospital-acquired bloodstream infection in Turkish intensive care units: a prospective observational cohort study. The Journal of Antimicrobial Chemotherapy. 2023;78(7):1757–1768. doi: 10.1093/jac/dkad167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jac/dkad167</ArticleId><ArticleId IdType="pmc">PMC10376926</ArticleId><ArticleId IdType="pubmed">37264485</ArticleId></ArticleIdList></Reference><Reference><Citation>Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, Al-Rabiah FA, Al-Hajjar S, Al-Barrak A, Flemban H, Al-Nassir WN, Balkhy HH, Al-Hakeem RF, Makhdoom HQ, Zumla AI, Memish ZA. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. The Lancet. Infectious Diseases. 2013;13(9):752–761. doi: 10.1016/S1473-3099(13)70204-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(13)70204-4</ArticleId><ArticleId IdType="pmc">PMC7185445</ArticleId><ArticleId IdType="pubmed">23891402</ArticleId></ArticleIdList></Reference><Reference><Citation>Azimi T, Maham S, Fallah F, Azimi L, Gholinejad Z. Evaluating the antimicrobial resistance patterns among major bacterial pathogens isolated from clinical specimens taken from patients in Mofid Children’s Hospital, Tehran, Iran: 2013–2018. Infection and Drug Resistance. 2019;12:2089–2102. doi: 10.2147/IDR.S215329.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IDR.S215329</ArticleId><ArticleId IdType="pmc">PMC6645606</ArticleId><ArticleId IdType="pubmed">31410032</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakaletz LO. Viral-bacterial co-infections in the respiratory tract. Current Opinion in Microbiology. 2017;35(Suppl. 1):30–35. doi: 10.1016/j.mib.2016.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mib.2016.11.003</ArticleId><ArticleId IdType="pmc">PMC7108227</ArticleId><ArticleId IdType="pubmed">27940028</ArticleId></ArticleIdList></Reference><Reference><Citation>Baskaran V, Lawrence H, Lansbury LE, Webb K, Safavi S, Zainuddin NI, Huq T, Eggleston C, Ellis J, Thakker C, Charles B, Boyd S, Williams T, Phillips C, Redmore E, Platt S, Hamilton E, Barr A, Venyo L, Wilson P, Bewick T, Daniel P, Dark P, Jeans AR, McCanny J, Edgeworth JD, Llewelyn MJ, Schmid ML, McKeever TM, Beed M, Lim WS. Co-infection in critically ill patients with COVID-19: an observational cohort study from England. Journal of Medical Microbiology. 2021;70(4):001350. doi: 10.1099/jmm.0.001350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jmm.0.001350</ArticleId><ArticleId IdType="pmc">PMC8289210</ArticleId><ArticleId IdType="pubmed">33861190</ArticleId></ArticleIdList></Reference><Reference><Citation>Bassetti M, Kollef MH, Timsit JF. Bacterial and fungal superinfections in critically ill patients with COVID-19. Intensive Care Medicine. 2020;46(11):2071–2074. doi: 10.1007/s00134-020-06219-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-06219-8</ArticleId><ArticleId IdType="pmc">PMC7479998</ArticleId><ArticleId IdType="pubmed">32902729</ArticleId></ArticleIdList></Reference><Reference><Citation>Bazaid AS, Barnawi H, Qanash H, Alsaif G, Aldarhami A, Gattan H, Alharbi B, Alrashidi A, Al-Soud WA, Moussa S, Alfouzan F. Bacterial coinfection and antibiotic resistance profiles among hospitalised COVID-19 patients. Microorganisms. 2022;10(3):495. doi: 10.3390/microorganisms10030495.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms10030495</ArticleId><ArticleId IdType="pmc">PMC8955474</ArticleId><ArticleId IdType="pubmed">35336071</ArticleId></ArticleIdList></Reference><Reference><Citation>Bengoechea JA, Bamford CG. SARS-CoV-2, bacterial co-infections, and AMR: the deadly trio in COVID-19. EMBO Molecular Medicine. 2020;12(7):e12560. doi: 10.15252/emmm.202012560.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.202012560</ArticleId><ArticleId IdType="pmc">PMC7283846</ArticleId><ArticleId IdType="pubmed">32453917</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernard-Raichon L, Venzon M, Klein J, Axelrad JE, Zhang C, Sullivan AP, Hussey GA, Casanovas-Massana A, Noval MG, Valero-Jimenez AM, Gago J, Putzel G, Pironti A, Wilder E, Yale IMPACT Research Team. Thorpe LE, Littman DR, Dittmann M, Stapleford KA, Shopsin B, Torres VJ, Ko AI, Iwasaki A, Cadwell K, Schluter J. Gut microbiome dysbiosis in antibiotic-treated COVID-19 patients is associated with microbial translocation and bacteremia. Nature Communications. 2022;13(1):5926. doi: 10.1038/s41467-022-33395-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-33395-6</ArticleId><ArticleId IdType="pmc">PMC9626559</ArticleId><ArticleId IdType="pubmed">36319618</ArticleId></ArticleIdList></Reference><Reference><Citation>Blonz G, Kouatchet A, Chudeau N, Pontis E, Lorber J, Lemeur A, Planche L, Lascarrou JB, Colin G. Epidemiology and microbiology of ventilator-associated pneumonia in COVID-19 patients: a multicenter retrospective study in 188 patients in an un-inundated French region. Critical Care: The Official Journal of the Critical Care Forum. 2021;25:72. doi: 10.1186/s13054-021-03493-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-021-03493-w</ArticleId><ArticleId IdType="pmc">PMC7891465</ArticleId><ArticleId IdType="pubmed">33602296</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonazzetti C, Morena V, Giacomelli A, Oreni L, Casalini G, Galimberti LR, Bolis M, Rimoldi M, Ballone E, Colombo R, Ridolfo AL, Antinori S. Unexpectedly high frequency of enterococcal bloodstream infections in coronavirus disease 2019 patients admitted to an Italian ICU: an observational study. Critical Care Medicine. 2021;49(1):e31–31e40. doi: 10.1097/CCM.0000000000004748.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000004748</ArticleId><ArticleId IdType="pmc">PMC7737701</ArticleId><ArticleId IdType="pubmed">33122577</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonazzetti C, Rinaldi M, Giacomelli A, Colombo R, Ottolina D, Rimoldi SG, Pagani C, Morena V, Ridolfo AL, Vatamanu O, Giacomini ME, Campoli C, Oreni L, Rizzardini G, Viale P, Antinori S, Giannella M. Risk factors associated with bacteremia in COVID-19 patients admitted to intensive care unit: a retrospective multicenter cohort study. Infection. 2023;51:129–136. doi: 10.1007/s15010-022-01853-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-022-01853-4</ArticleId><ArticleId IdType="pmc">PMC9185127</ArticleId><ArticleId IdType="pubmed">35687293</ArticleId></ArticleIdList></Reference><Reference><Citation>Budinger G, Misharin AV, Ridge KM, Singer BD, Wunderink RG. Distinctive features of severe SARS-CoV-2 pneumonia. The Journal of Clinical Investigation. 2021;131(14):e149412. doi: 10.1172/JCI149412.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI149412</ArticleId><ArticleId IdType="pmc">PMC8279580</ArticleId><ArticleId IdType="pubmed">34263736</ArticleId></ArticleIdList></Reference><Reference><Citation>Buetti N, Ruckly S, de Montmollin E, Reignier J, Terzi N, Cohen Y, Siami S, Dupuis C, Timsit JF. COVID-19 increased the risk of ICU-acquired bloodstream infections: a case-cohort study from the multicentric OUTCOMEREA network. Intensive Care Medicine. 2021;47(2):180–187. doi: 10.1007/s00134-021-06346-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-021-06346-w</ArticleId><ArticleId IdType="pmc">PMC7839935</ArticleId><ArticleId IdType="pubmed">33506379</ArticleId></ArticleIdList></Reference><Reference><Citation>Buetti N, Tabah A, Loiodice A, Ruckly S, Aslan AT, Montrucchio G, Cortegiani A, Saltoglu N, Kayaaslan B, Aksoy F, Murat A, Akdoğan Ö, Saracoglu KT, Erdogan C, Leone M, Ferrer R, Paiva JA, Hayashi Y, Ramanan M, Conway Morris A, Barbier F, Timsit JF, Eurobact 2 study group Different epidemiology of bloodstream infections in COVID-19 compared to non-COVID-19 critically ill patients: a descriptive analysis of the Eurobact II study. Critical Care: The Official Journal of the Critical Care Forum. 2022;26:319. doi: 10.1186/s13054-022-04166-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-022-04166-y</ArticleId><ArticleId IdType="pmc">PMC9578203</ArticleId><ArticleId IdType="pubmed">36258239</ArticleId></ArticleIdList></Reference><Reference><Citation>Caruso P, Maiorino MI, Macera M, Signoriello G, Castellano L, Scappaticcio L, Longo M, Gicchino M, Campitiello F, Bellastella G, Coppola N, Esposito K. Antibiotic resistance in diabetic foot infection: how it changed with COVID-19 pandemic in a tertiary care center. Diabetes Research and Clinical Practice. 2021;175(36):108797. doi: 10.1016/j.diabres.2021.108797.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2021.108797</ArticleId><ArticleId IdType="pmc">PMC8047299</ArticleId><ArticleId IdType="pubmed">33845049</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X, Zhang L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513. doi: 10.1016/S0140-6736(20)30211-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30211-7</ArticleId><ArticleId IdType="pmc">PMC7135076</ArticleId><ArticleId IdType="pubmed">32007143</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng K, He M, Shu Q, Wu M, Chen C, Xue Y. Analysis of the risk factors for nosocomial bacterial infection in patients with COVID-19 in a tertiary hospital. Risk Management and Healthcare Policy. 2020;13:2593–2599. doi: 10.2147/RMHP.S277963.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/RMHP.S277963</ArticleId><ArticleId IdType="pmc">PMC7671853</ArticleId><ArticleId IdType="pubmed">33223859</ArticleId></ArticleIdList></Reference><Reference><Citation>Chien YW, Klugman KP, Morens DM. Bacterial pathogens and death during the 1918 influenza pandemic. The New England Journal of Medicine. 2009;361(26):2582–2583. doi: 10.1056/NEJMc0908216.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc0908216</ArticleId><ArticleId IdType="pubmed">20032332</ArticleId></ArticleIdList></Reference><Reference><Citation>Clancy CJ, Schwartz IS, Kula B, Nguyen MH. Bacterial superinfections among persons with coronavirus disease 2019: a comprehensive review of data from postmortem studies. Open Forum Infectious Diseases. 2021;8(3):ofab065. doi: 10.1093/ofid/ofab065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab065</ArticleId><ArticleId IdType="pmc">PMC7928570</ArticleId><ArticleId IdType="pubmed">33732753</ArticleId></ArticleIdList></Reference><Reference><Citation>Cona A, Tavelli A, Renzelli A, Varisco B, Bai F, Tesoro D, Za A, Biassoni C, Battaglioli L, Allegrini M, Viganò O, Gazzola L, Bini T, Marchetti GC, d’Arminio Monforte A. Incidence, risk factors and impact on clinical outcomes of bloodstream infections in patients hospitalised with COVID-19: a prospective cohort study. Antibiotics. 2021;10(9):1031. doi: 10.3390/antibiotics10091031.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antibiotics10091031</ArticleId><ArticleId IdType="pmc">PMC8470708</ArticleId><ArticleId IdType="pubmed">34572613</ArticleId></ArticleIdList></Reference><Reference><Citation>Council of Canadian Academies  When antibiotics fail: the expert panel on the potential socio-economic impacts of antimicrobial resistance in Canada. 2021. http://www.deslibris.ca/ID/10102747. http://www.deslibris.ca/ID/10102747 (accessed 20 September 2021)</Citation></Reference><Reference><Citation>COVID-ICU Group on Behalf of the REVA Network and the COVID-ICU Investigators Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study. Intensive Care Medicine. 2021;47:60–73. doi: 10.1007/s00134-020-06294-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-06294-x</ArticleId><ArticleId IdType="pmc">PMC7674575</ArticleId><ArticleId IdType="pubmed">33211135</ArticleId></ArticleIdList></Reference><Reference><Citation>de Carvalho Hessel Dias VM, Tuon F, de Jesus Capelo P, Telles JP, Fortaleza C, Pellegrino Baena C. Trend analysis of carbapenem-resistant Gram-negative bacteria and antimicrobial consumption in the post-COVID-19 era: an extra challenge for healthcare institutions. The Journal of Hospital Infection. 2022;120:43–47. doi: 10.1016/j.jhin.2021.11.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhin.2021.11.011</ArticleId><ArticleId IdType="pmc">PMC8603865</ArticleId><ArticleId IdType="pubmed">34808311</ArticleId></ArticleIdList></Reference><Reference><Citation>Denina M, Pellegrino F, Morotti F, Coppo P, Bonsignori IM, Garazzino S, Ravanini P, Avolio M, Cavallo R, Bertolotti L, Felici E, Acucella G, Montin D, Rabbone I, Licciardi F. All that glisters is not COVID: low prevalence of seroconversion against SARS-CoV-2 in a pediatric cohort of patients with chilblain-like lesions. Journal of the American Academy of Dermatology. 2020;83(6):1751–1753. doi: 10.1016/j.jaad.2020.08.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaad.2020.08.021</ArticleId><ArticleId IdType="pmc">PMC7414307</ArticleId><ArticleId IdType="pubmed">32781180</ArticleId></ArticleIdList></Reference><Reference><Citation>Despotovic A, Milosevic B, Cirkovic A, Vujovic A, Cucanic K, Cucanic T, Stevanovic G. The impact of COVID-19 on the profile of hospital-acquired infections in adult intensive care units. Antibiotics. 2021;10(10):1146. doi: 10.3390/antibiotics10101146.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antibiotics10101146</ArticleId><ArticleId IdType="pmc">PMC8532680</ArticleId><ArticleId IdType="pubmed">34680727</ArticleId></ArticleIdList></Reference><Reference><Citation>Dheda K, Booth H, Huggett JF, Johnson MA, Zumla A, Rook GA. Lung remodeling in pulmonary tuberculosis. The Journal of Infectious Diseases. 2005;192(7):1201–1209. doi: 10.1086/444545.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/444545</ArticleId><ArticleId IdType="pubmed">16136463</ArticleId></ArticleIdList></Reference><Reference><Citation>Effah CY, Sun T, Liu S, Wu Y. Klebsiella pneumoniae: an increasing threat to public health. Annals of Clinical Microbiology and Antimicrobials. 2020;19(1):1. doi: 10.1186/s12941-019-0343-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12941-019-0343-8</ArticleId><ArticleId IdType="pmc">PMC7050612</ArticleId><ArticleId IdType="pubmed">31918737</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan J, Li X, Gao Y, Zhou J, Wang S, Huang B, Wu J, Cao Q, Chen Y, Wang Z, Luo D, Zhou T, Li R, Shang Y, Nie X. The lung tissue microbiota features of 20 deceased patients with COVID-19. The Journal of Infection. 2020;81(3):e64–64e67. doi: 10.1016/j.jinf.2020.06.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.06.047</ArticleId><ArticleId IdType="pmc">PMC7306202</ArticleId><ArticleId IdType="pubmed">32579991</ArticleId></ArticleIdList></Reference><Reference><Citation>Frija-Masson J, Debray MP, Gilbert M, Lescure FX, Travert F, Borie R, Khalil A, Crestani B, d’Ortho MP, Bancal C. Functional characteristics of patients with SARS-CoV-2 pneumonia at 30 days post-infection. The European Respiratory Journal. 2020;56(2) doi: 10.1183/13993003.01754-2020. 2001754–2002020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01754-2020</ArticleId><ArticleId IdType="pmc">PMC7301832</ArticleId><ArticleId IdType="pubmed">32554533</ArticleId></ArticleIdList></Reference><Reference><Citation>Gago J, Filardo TD, Conderino S, Magaziner SJ, Dubrovskaya Y, Inglima K, Iturrate E, Pironti A, Schluter J, Cadwell K, Hochman S, Li H, Torres VJ, Thorpe LE, Shopsin B. Pathogen species is associated with mortality in nosocomial bloodstream infection in patients with COVID-19. Open Forum Infectious Diseases. 2022;9(6):ofac083. doi: 10.1093/ofid/ofac083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac083</ArticleId><ArticleId IdType="pmc">PMC8992347</ArticleId><ArticleId IdType="pubmed">35607701</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Vidal C, Sanjuan G, Moreno-García E, Puerta-Alcalde P, Garcia-Pouton N, Chumbita M, Fernandez-Pittol M, Pitart C, Inciarte A, Bodro M, Morata L, Ambrosioni J, Grafia I, Meira F, Macaya I, Cardozo C, Casals C, Tellez A, Castro P, Marco F, García F, Mensa J, Martínez JA, Soriano A, COVID-19 Researchers Group Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study. Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. 2021;27:83–88. doi: 10.1016/j.cmi.2020.07.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.07.041</ArticleId><ArticleId IdType="pmc">PMC7836762</ArticleId><ArticleId IdType="pubmed">32745596</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaspar GG, Ferreira LR, Feliciano CS, Campos Júnior CP, Molina F, Vendruscolo A, Bradan G, Lopes N, Martinez R, Bollela VR. Pre- and post-COVID-19 evaluation of antimicrobial susceptibility for healthcare-associated infections in the intensive care unit of a tertiary hospital. Revista da Sociedade Brasileira de Medicina Tropical. 2021;54(9):e00902021. doi: 10.1590/0037-8682-0090-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/0037-8682-0090-2021</ArticleId><ArticleId IdType="pmc">PMC8313097</ArticleId><ArticleId IdType="pubmed">34320129</ArticleId></ArticleIdList></Reference><Reference><Citation>Giacobbe DR, Battaglini D, Ball L, Brunetti I, Bruzzone B, Codda G, Crea F, De Maria A, Dentone C, Di Biagio A, Icardi G, Magnasco L, Marchese A, Mikulska M, Orsi A, Patroniti N, Robba C, Signori A, Taramasso L, Vena A, Pelosi P, Bassetti M. Bloodstream infections in critically ill patients with COVID-19. European Journal of Clinical Investigation. 2020;50(10):e13319. doi: 10.1111/eci.13319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eci.13319</ArticleId><ArticleId IdType="pmc">PMC7323143</ArticleId><ArticleId IdType="pubmed">32535894</ArticleId></ArticleIdList></Reference><Reference><Citation>Giacobbe DR, Battaglini D, Enrile EM, Dentone C, Vena A, Robba C, Ball L, Bartoletti M, Coloretti I, Di Bella S, Di Biagio A, Brunetti I, Mikulska M, Carannante N, De Maria A, Magnasco L, Maraolo AE, Mirabella M, Montrucchio G, Patroniti N, Taramasso L, Tiseo G, Fornaro G, Fraganza F, Monastra L, Roman-Pognuz E, Paluzzano G, Fiorentino G, Corcione A, Bussini L, Pascale R, Corcione S, Tonetti T, Rinaldi M, Falcone M, Biagioni E, Ranieri VM, Giannella M, De Rosa FG, Girardis M, Menichetti F, Viale P, Pelosi P, Bassetti M. Incidence and prognosis of ventilator-associated pneumonia in critically ill patients with COVID-19: a multicenter study. Journal of Clinical Medicine. 2021;10(4):555. doi: 10.3390/jcm10040555.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10040555</ArticleId><ArticleId IdType="pmc">PMC7913191</ArticleId><ArticleId IdType="pubmed">33546093</ArticleId></ArticleIdList></Reference><Reference><Citation>Gisselø KL, Rubin I, Knudsen MS, From-Hansen M, Stangerup M, Kavalaris CP, Pinholt M, Mollerup S, Westh H, Bartels MD, Petersen AM. Substantial decrease in vancomycin-resistant enterococcus faecium outbreak duration and number of patients during the danish COVID-19 lockdown: a prospective observational study. Microbial Drug Resistance: MDR: Mechanisms, Epidemiology, and Disease. 2022;28:73–80. doi: 10.1089/mdr.2021.0040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/mdr.2021.0040</ArticleId><ArticleId IdType="pubmed">34491861</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomez-Simmonds A, Annavajhala MK, McConville TH, Dietz DE, Shoucri SM, Laracy JC, Rozenberg FD, Nelson B, Greendyke WG, Furuya EY, Whittier S, Uhlemann AC. Carbapenemase-producing Enterobacterales causing secondary infections during the COVID-19 crisis at a New York City hospital. The Journal of Antimicrobial Chemotherapy. 2021;76(2):380–384. doi: 10.1093/jac/dkaa466.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jac/dkaa466</ArticleId><ArticleId IdType="pmc">PMC7717307</ArticleId><ArticleId IdType="pubmed">33202023</ArticleId></ArticleIdList></Reference><Reference><Citation>Goncalves Mendes Neto A, Lo KB, Wattoo A, Salacup G, Pelayo J, DeJoy R, 3rd, Bhargav R, Gul F, Peterson E, Albano J, Patarroyo-Aponte G, Rangaswami J, Azmaiparashvili Z. Bacterial infections and patterns of antibiotic use in patients with COVID-19. Journal of Medical Virology. 2021;93(3):1489–1495. doi: 10.1002/jmv.26441.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26441</ArticleId><ArticleId IdType="pmc">PMC7461450</ArticleId><ArticleId IdType="pubmed">32808695</ArticleId></ArticleIdList></Reference><Reference><Citation>Goyal P, Choi JJ, Pinheiro LC, Schenck EJ, Chen R, Jabri A, Satlin MJ, Campion TR, Jr, Nahid M, Ringel JB, Hoffman KL, Alshak MN, Li HA, Wehmeyer GT, Rajan M, Reshetnyak E, Hupert N, Horn EM, Martinez FJ, Gulick RM, Safford MM. Clinical characteristics of covid-19 in New York City. The New England Journal of Medicine. 2020;382(24):2372–2374. doi: 10.1056/NEJMc2010419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2010419</ArticleId><ArticleId IdType="pmc">PMC7182018</ArticleId><ArticleId IdType="pubmed">32302078</ArticleId></ArticleIdList></Reference><Reference><Citation>Gragueb-Chatti I, Lopez A, Hamidi D, Guervilly C, Loundou A, Daviet F, Cassir N, Papazian L, Forel JM, Leone M, Dellamonica J, Hraiech S. Impact of dexamethasone on the incidence of ventilator-associated pneumonia and blood stream infections in COVID-19 patients requiring invasive mechanical ventilation: a multicenter retrospective study. Annals of Intensive Care. 2021;11:87. doi: 10.1186/s13613-021-00876-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-021-00876-8</ArticleId><ArticleId IdType="pmc">PMC8165680</ArticleId><ArticleId IdType="pubmed">34057642</ArticleId></ArticleIdList></Reference><Reference><Citation>Grasselli G, Cattaneo E, Florio G, Ippolito M, Zanella A, Cortegiani A, Huang J, Pesenti A, Einav S. Mechanical ventilation parameters in critically ill COVID-19 patients: a scoping review. Critical Care: The Official Journal of the Critical Care Forum. 2021a;25:115. doi: 10.1186/s13054-021-03536-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-021-03536-2</ArticleId><ArticleId IdType="pmc">PMC7980724</ArticleId><ArticleId IdType="pubmed">33743812</ArticleId></ArticleIdList></Reference><Reference><Citation>Grasselli G, Scaravilli V, Di Bella S, Biffi S, Bombino M, Patroniti N, Bisi L, Peri AM, Pesenti A, Gori A, Alagna L. Nosocomial infections during extracorporeal membrane oxygenation: incidence, etiology, and impact on patients’ outcome. Critical Care Medicine. 2017;45(10):1726–1733. doi: 10.1097/CCM.0000000000002652.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000002652</ArticleId><ArticleId IdType="pubmed">28777198</ArticleId></ArticleIdList></Reference><Reference><Citation>Grasselli G, Scaravilli V, Mangioni D, Scudeller L, Alagna L, Bartoletti M, Bellani G, Biagioni E, Bonfanti P, Bottino N, Coloretti I, Cutuli SL, De Pascale G, Ferlicca D, Fior G, Forastieri A, Franzetti M, Greco M, Guzzardella A, Linguadoca S, Meschiari M, Messina A, Monti G, Morelli P, Muscatello A, Redaelli S, Stefanini F, Tonetti T, Antonelli M, Cecconi M, Foti G, Fumagalli R, Girardis M, Ranieri M, Viale P, Raviglione M, Pesenti A, Gori A, Bandera A. Hospital-acquired infections in critically ill patients with COVID-19. Chest. 2021b;160(2):454–465. doi: 10.1016/j.chest.2021.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2021.04.002</ArticleId><ArticleId IdType="pmc">PMC8056844</ArticleId><ArticleId IdType="pubmed">33857475</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui D, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS, China Medical Treatment Expert Group for Covid-19 Clinical characteristics of coronavirus disease 2019 in China. The New England Journal of Medicine. 2020;382(18):1708–1720. doi: 10.1056/NEJMoa2002032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2002032</ArticleId><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Gysin M, Acevedo CT, Haldimann K, Bodendoerfer E, Imkamp F, Bulut K, Buehler PK, Brugger SD, Becker K, Hobbie SN. Antimicrobial susceptibility patterns of respiratory Gram-negative bacterial isolates from COVID-19 patients in Switzerland. Annals of Clinical Microbiology and Antimicrobials. 2021;20:64. doi: 10.1186/s12941-021-00468-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12941-021-00468-1</ArticleId><ArticleId IdType="pmc">PMC8422836</ArticleId><ArticleId IdType="pubmed">34493302</ArticleId></ArticleIdList></Reference><Reference><Citation>He Y, Li W, Wang Z, Chen H, Tian L, Liu D. Nosocomial infection among patients with COVID-19: a retrospective data analysis of 918 cases from a single center in Wuhan, China. Infection Control and Hospital Epidemiology. 2020;41(8):982–983. doi: 10.1017/ice.2020.126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/ice.2020.126</ArticleId><ArticleId IdType="pmc">PMC7180328</ArticleId><ArticleId IdType="pubmed">32279676</ArticleId></ArticleIdList></Reference><Reference><Citation>Hedberg P, Ternhag A, Giske CG, Strålin K, Özenci V, Johansson N, Spindler C, Hedlund J, Mårtensson J, Nauclér P. Ventilator-associated lower respiratory tract bacterial infections in COVID-19 compared with non-COVID-19 patients. Critical Care Medicine. 2022;50(5):825–836. doi: 10.1097/CCM.0000000000005462.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000005462</ArticleId><ArticleId IdType="pmc">PMC9005099</ArticleId><ArticleId IdType="pubmed">35148524</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoque MN, Akter S, Mishu ID, Islam MR, Rahman MS, Akhter M, Islam I, Hasan MM, Rahaman MM, Sultana M, Islam T, Hossain MA. Microbial co-infections in COVID-19: associated microbiota and underlying mechanisms of pathogenesis. Microbial Pathogenesis. 2021a;156(10229):104941. doi: 10.1016/j.micpath.2021.104941.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micpath.2021.104941</ArticleId><ArticleId IdType="pmc">PMC8095020</ArticleId><ArticleId IdType="pubmed">33962007</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoque MN, Rahman MS, Ahmed R, Hossain MS, Islam MS, Islam T, Hossain MA, Siddiki AZ. Diversity and genomic determinants of the microbiomes associated with COVID-19 and non-COVID respiratory diseases. Gene Reports. 2021b;23(33):101200. doi: 10.1016/j.genrep.2021.101200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genrep.2021.101200</ArticleId><ArticleId IdType="pmc">PMC8102076</ArticleId><ArticleId IdType="pubmed">33977168</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu J. How Covid-19 is accelerating the threat of antimicrobial resistance. BMJ: British Medical Journal. 2020;369:m1983. doi: 10.1136/bmj.m1983.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1983</ArticleId><ArticleId IdType="pubmed">32423901</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi: 10.1016/S0140-6736(20)30183-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes S, Troise O, Donaldson H, Mughal N, Moore L. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting. Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. 2020;26(10):1395–1399. doi: 10.1016/j.cmi.2020.06.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.06.025</ArticleId><ArticleId IdType="pmc">PMC7320692</ArticleId><ArticleId IdType="pubmed">32603803</ArticleId></ArticleIdList></Reference><Reference><Citation>Ippolito M, Simone B, Filisina C, Catalanotto FR, Catalisano G, Marino C, Misseri G, Giarratano A, Cortegiani A. Bloodstream infections in hospitalized patients with COVID-19: a systematic review and meta-analysis. Microorganisms. 2021;9(10):2016. doi: 10.3390/microorganisms9102016.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9102016</ArticleId><ArticleId IdType="pmc">PMC8540195</ArticleId><ArticleId IdType="pubmed">34683337</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamnani AN, Montazeri M, Mirzakhani M, Moosazadeh M, Haghighi M. Evaluation of bacterial coinfection and antibiotic resistance in patients with COVID-19 under mechanical ventilation. SN Comprehensive Clinical Medicine. 2022;4:19. doi: 10.1007/s42399-021-01114-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42399-021-01114-9</ArticleId><ArticleId IdType="pmc">PMC8733817</ArticleId><ArticleId IdType="pubmed">35013721</ArticleId></ArticleIdList></Reference><Reference><Citation>Joseph C, Togawa Y, Shindo N. Bacterial and viral infections associated with influenza. Influenza and Other Respiratory Viruses. 2013;7(Suppl 2):105–113. doi: 10.1111/irv.12089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/irv.12089</ArticleId><ArticleId IdType="pmc">PMC5909385</ArticleId><ArticleId IdType="pubmed">24034494</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang H, Stewart KO, Khan AN, Casale SC, Adams Barker CM, Kim JJ. Investigating potential drivers of increased central line-associated bloodstream infections during the coronavirus disease 2019 (COVID-19) Omicron surge. American Journal of Infection Control. 2023;51(10):1196–1199. doi: 10.1016/j.ajic.2023.04.168.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajic.2023.04.168</ArticleId><ArticleId IdType="pmc">PMC10129334</ArticleId><ArticleId IdType="pubmed">37105358</ArticleId></ArticleIdList></Reference><Reference><Citation>Karagiannidis C, Mostert C, Hentschker C, Voshaar T, Malzahn J, Schillinger G, Klauber J, Janssens U, Marx G, Weber-Carstens S, Kluge S, Pfeifer M, Grabenhenrich L, Welte T, Busse R. Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study. The Lancet. Respiratory Medicine. 2020;8(9):853–862. doi: 10.1016/S2213-2600(20)30316-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30316-7</ArticleId><ArticleId IdType="pmc">PMC7386882</ArticleId><ArticleId IdType="pubmed">32735842</ArticleId></ArticleIdList></Reference><Reference><Citation>Kariyawasam RM, Julien DA, Jelinski DC, Larose SL, Rennert-May E, Conly JM, Dingle TC, Chen JZ, Tyrrell GJ, Ronksley PE, Barkema HW. Antimicrobial resistance (AMR) in COVID-19 patients: a systematic review and meta-analysis (November 2019–June 2021) Antimicrobial Resistance and Infection Control. 2022;11(1):45. doi: 10.1186/s13756-022-01085-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13756-022-01085-z</ArticleId><ArticleId IdType="pmc">PMC8899460</ArticleId><ArticleId IdType="pubmed">35255988</ArticleId></ArticleIdList></Reference><Reference><Citation>Khatiwada S, Subedi A. Lung microbiome and coronavirus disease 2019 (COVID-19): possible link and implications. Human Microbiome Journal. 2020;17(16):100073. doi: 10.1016/j.humic.2020.100073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.humic.2020.100073</ArticleId><ArticleId IdType="pmc">PMC7405772</ArticleId><ArticleId IdType="pubmed">32835135</ArticleId></ArticleIdList></Reference><Reference><Citation>Khatri A, Malhotra P, Izard S, Kim A, Oppenheim M, Gautam-Goyal P, Chen T, Doan TL, Berlinrut I, Niknam N, Flannery S, Hirschwerk D, Epstein M, Farber B. Hospital-acquired bloodstream infections in patients hospitalized with severe acute respiratory syndrome coronavirus 2 infection (Coronavirus Disease 2019): association with immunosuppressive therapies. Open Forum Infectious Diseases. 2021;8(7):ofab339. doi: 10.1093/ofid/ofab339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab339</ArticleId><ArticleId IdType="pmc">PMC8320294</ArticleId><ArticleId IdType="pubmed">34337096</ArticleId></ArticleIdList></Reference><Reference><Citation>Kılıç L, Altın S, Gönenç Ortaköylü M, Kanmaz ZD, Tutar T, Özkan GZ. Co-infection of COVID-19 and tuberculosis. Turkish Thoracic Journal. 2022;23:58–62. doi: 10.5152/TurkThoracJ.2022.21045.</Citation><ArticleIdList><ArticleId IdType="doi">10.5152/TurkThoracJ.2022.21045</ArticleId><ArticleId IdType="pmc">PMC9450003</ArticleId><ArticleId IdType="pubmed">35110202</ArticleId></ArticleIdList></Reference><Reference><Citation>Kokkoris S, Papachatzakis I, Gavrielatou E, Ntaidou T, Ischaki E, Malachias S, Vrettou C, Nichlos C, Kanavou A, Zervakis D, Perivolioti E, Ranellou K, Argyropoulou A, Zakynthinos S, Kotanidou A, Routsi C. ICU-acquired bloodstream infections in critically ill patients with COVID-19. The Journal of Hospital Infection. 2021;107:95–97. doi: 10.1016/j.jhin.2020.11.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhin.2020.11.009</ArticleId><ArticleId IdType="pmc">PMC7671926</ArticleId><ArticleId IdType="pubmed">33217490</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurt AF, Mete B, Urkmez S, Demirkiran O, Dumanli GY, Bozbay S, Dilken O, Karaali R, Balkan II, Saltoğlu N, Dikmen Y, Tabak F, Aygun G. Incidence, risk factors, and prognosis of bloodstream infections in COVID-19 patients in intensive care: a single-center observational study. Journal of Intensive Care Medicine. 2022;37(10):1353–1362. doi: 10.1177/08850666221103495.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/08850666221103495</ArticleId><ArticleId IdType="pmc">PMC9130876</ArticleId><ArticleId IdType="pubmed">35607286</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuwahara M, Kamigaito M, Nitta S, Hasegawa K, Murakami H, Kobayashi T, Shirai K, Kohama K, Hirata JI. Effect of tocilizumab treatment on patients with coronavirus disease 2019 and bacteremia: a retrospective cohort study. Infectious Diseases and Therapy. 2022;11:533–541. doi: 10.1007/s40121-022-00592-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40121-022-00592-1</ArticleId><ArticleId IdType="pmc">PMC8775152</ArticleId><ArticleId IdType="pubmed">35060111</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai CC, Chen SY, Ko WC, Hsueh PR. Increased antimicrobial resistance during the COVID-19 pandemic. International Journal of Antimicrobial Agents. 2021;57(4):106324. doi: 10.1016/j.ijantimicag.2021.106324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2021.106324</ArticleId><ArticleId IdType="pmc">PMC7972869</ArticleId><ArticleId IdType="pubmed">33746045</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai CC, Wang CY, Hsueh PR. Co-infections among patients with COVID-19: the need for combination therapy with non-anti-SARS-CoV-2 agents. Journal of Microbiology, Immunology, and Infection. 2020;53(4):505–512. doi: 10.1016/j.jmii.2020.05.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2020.05.013</ArticleId><ArticleId IdType="pmc">PMC7245213</ArticleId><ArticleId IdType="pubmed">32482366</ArticleId></ArticleIdList></Reference><Reference><Citation>Lal A, Mishra AK, Sahu KK, Abraham GM. The return of Koch’s: ineffective treatment or re-infection. Enfermedades Infecciosas y Microbiologia Clinica (English ed.) 2020;38(3):144–145. doi: 10.1016/j.eimc.2019.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eimc.2019.06.001</ArticleId><ArticleId IdType="pubmed">31307825</ArticleId></ArticleIdList></Reference><Reference><Citation>Langford BJ, So M, Raybardhan S, Leung V, Soucy JR, Westwood D, Daneman N, MacFadden DR. Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis. Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. 2021;27(4):520–531. doi: 10.1016/j.cmi.2020.12.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.12.018</ArticleId><ArticleId IdType="pmc">PMC7785281</ArticleId><ArticleId IdType="pubmed">33418017</ArticleId></ArticleIdList></Reference><Reference><Citation>Langford BJ, So M, Raybardhan S, Leung V, Westwood D, MacFadden DR, Soucy JR, Daneman N. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. 2020;26(12):1622–1629. doi: 10.1016/j.cmi.2020.07.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.07.016</ArticleId><ArticleId IdType="pmc">PMC7832079</ArticleId><ArticleId IdType="pubmed">32711058</ArticleId></ArticleIdList></Reference><Reference><Citation>Langford BJ, So M, Simeonova M, Leung V, Lo J, Kan T, Raybardhan S, Sapin ME, Mponponsuo K, Farrell A, Leung E, Soucy JR, Cassini A, MacFadden D, Daneman N, Bertagnolio S. Antimicrobial resistance in patients with COVID-19: a systematic review and meta-analysis. The Lancet. Microbe. 2023;4(3):e179–e191. doi: 10.1016/S2666-5247(22)00355-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(22)00355-X</ArticleId><ArticleId IdType="pmc">PMC9889096</ArticleId><ArticleId IdType="pubmed">36736332</ArticleId></ArticleIdList></Reference><Reference><Citation>Laupland KB, Church DL. Population-based epidemiology and microbiology of community-onset bloodstream infections. Clinical Microbiology Reviews. 2014;27(4):647–664. doi: 10.1128/CMR.00002-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00002-14</ArticleId><ArticleId IdType="pmc">PMC4187633</ArticleId><ArticleId IdType="pubmed">25278570</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R, Pei S, Chen B, Song Y, Zhang T, Yang W, Shaman J. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2) Science. 2020a;368(6490):489–493. doi: 10.1126/science.abb3221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb3221</ArticleId><ArticleId IdType="pmc">PMC7164387</ArticleId><ArticleId IdType="pubmed">32179701</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Wang J, Yang Y, Cai P, Cao J, Cai X, Zhang Y. Etiology and antimicrobial resistance of secondary bacterial infections in patients hospitalized with COVID-19 in Wuhan, China: a retrospective analysis. Antimicrobial Resistance and Infection Control. 2020b;9:153. doi: 10.1186/s13756-020-00819-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13756-020-00819-1</ArticleId><ArticleId IdType="pmc">PMC7506844</ArticleId><ArticleId IdType="pubmed">32962731</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle. Journal of Medical Virology. 2020;92(4):401–402. doi: 10.1002/jmv.25678.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25678</ArticleId><ArticleId IdType="pmc">PMC7166628</ArticleId><ArticleId IdType="pubmed">31950516</ArticleId></ArticleIdList></Reference><Reference><Citation>Luyt CE, Sahnoun T, Gautier M, Vidal P, Burrel S, Pineton de Chambrun M, Chommeloux J, Desnos C, Arzoine J, Nieszkowska A, Bréchot N, Schmidt M, Hekimian G, Boutolleau D, Robert J, Combes A, Chastre J. Ventilator-associated pneumonia in patients with SARS-CoV-2-associated acute respiratory distress syndrome requiring ECMO: a retrospective cohort study. Annals of Intensive Care. 2020;10:158. doi: 10.1186/s13613-020-00775-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-020-00775-4</ArticleId><ArticleId IdType="pmc">PMC7682692</ArticleId><ArticleId IdType="pubmed">33230710</ArticleId></ArticleIdList></Reference><Reference><Citation>MacIntyre CR, Chughtai AA, Barnes M, Ridda I, Seale H, Toms R, Heywood A. The role of pneumonia and secondary bacterial infection in fatal and serious outcomes of pandemic influenza a(H1N1)pdm09. BMC Infectious Diseases. 2018;18:637. doi: 10.1186/s12879-018-3548-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-018-3548-0</ArticleId><ArticleId IdType="pmc">PMC6286525</ArticleId><ArticleId IdType="pubmed">30526505</ArticleId></ArticleIdList></Reference><Reference><Citation>Maes M, Higginson E, Pereira-Dias J, Curran MD, Parmar S, Khokhar F, Cuchet-Lourenço D, Lux J, Sharma-Hajela S, Ravenhill B, Hamed I, Heales L, Mahroof R, Soderholm A, Forrest S, Sridhar S, Brown NM, Baker S, Navapurkar V, Dougan G, Bartholdson Scott J, Conway Morris A. Ventilator-associated pneumonia in critically ill patients with COVID-19. Critical Care: The Official Journal of the Critical Care Forum. 2021;25:25. doi: 10.1186/s13054-021-03460-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-021-03460-5</ArticleId><ArticleId IdType="pmc">PMC7797892</ArticleId><ArticleId IdType="pubmed">33430915</ArticleId></ArticleIdList></Reference><Reference><Citation>Massart N, Maxime V, Fillatre P, Razazi K, Ferré A, Moine P, Legay F, Voiriot G, Amara M, Santi F, Nseir S, Marque-Juillet S, Bounab R, Barbarot N, Bruneel F, Luyt CE, COVID ICU Bacteremia Study Group on behalf of the COVID-ICU Investigators Characteristics and prognosis of bloodstream infection in patients with COVID-19 admitted in the ICU: an ancillary study of the COVID-ICU study. Annals of Intensive Care. 2021;11:183. doi: 10.1186/s13613-021-00971-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-021-00971-w</ArticleId><ArticleId IdType="pmc">PMC8708508</ArticleId><ArticleId IdType="pubmed">34952960</ArticleId></ArticleIdList></Reference><Reference><Citation>Massey BW, Jayathilake K, Meltzer HY. Respiratory microbial co-infection with SARS-CoV-2. Frontiers in Microbiology. 2020;11:2079. doi: 10.3389/fmicb.2020.02079.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.02079</ArticleId><ArticleId IdType="pmc">PMC7477285</ArticleId><ArticleId IdType="pubmed">32983056</ArticleId></ArticleIdList></Reference><Reference><Citation>Mastrogianni M, Katsoulas T, Galanis P, Korompeli A, Myrianthefs P. The impact of care bundles on ventilator-associated pneumonia (VAP) prevention in adult ICUs: a systematic review. Antibiotics. 2023;12(2):227. doi: 10.3390/antibiotics12020227.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antibiotics12020227</ArticleId><ArticleId IdType="pmc">PMC9952750</ArticleId><ArticleId IdType="pubmed">36830138</ArticleId></ArticleIdList></Reference><Reference><Citation>Meynaar IA, van Rijn S, Ottens TH, van Burgel ND, van Nieuwkoop C. Increased risk of central line-associated bloodstream infection in COVID-19 patients associated with dexamethasone but not with interleukin antagonists. Intensive Care Medicine. 2022;48(7):954–957. doi: 10.1007/s00134-022-06750-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-022-06750-w</ArticleId><ArticleId IdType="pmc">PMC9171741</ArticleId><ArticleId IdType="pubmed">35670819</ArticleId></ArticleIdList></Reference><Reference><Citation>Migliori GB, Visca D, van den Boom M, Tiberi S, Silva DR, Centis R, D’Ambrosio L, Thomas T, Pontali E, Saderi L, Schaaf HS, Sotgiu G, contributing members of the Global Tuberculosis Network Tuberculosis, COVID-19 and hospital admission: consensus on pros and cons based on a review of the evidence. Pulmonology. 2021;27(3):248–256. doi: 10.1016/j.pulmoe.2020.12.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pulmoe.2020.12.016</ArticleId><ArticleId IdType="pmc">PMC7843149</ArticleId><ArticleId IdType="pubmed">33547028</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo X, Jian W, Su Z, Chen M, Peng H, Peng P, Lei C, Chen R, Zhong N, Li S. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. The European Respiratory Journal. 2020;55(6) doi: 10.1183/13993003.01217-2020. 2001217–2002020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01217-2020</ArticleId><ArticleId IdType="pmc">PMC7236826</ArticleId><ArticleId IdType="pubmed">32381497</ArticleId></ArticleIdList></Reference><Reference><Citation>Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. The Journal of Infectious Diseases. 2008;198(7):962–970. doi: 10.1086/591708.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/591708</ArticleId><ArticleId IdType="pmc">PMC2599911</ArticleId><ArticleId IdType="pubmed">18710327</ArticleId></ArticleIdList></Reference><Reference><Citation>Mormeneo Bayo S, Palacián Ruíz MP, Moreno Hijazo M, Villuendas Usón MC. Bacteremia during COVID-19 pandemic in a tertiary hospital in Spain. Enfermedades infecciosas y microbiologia clinica (English ed.) 2022;40(4):183–186. doi: 10.1016/j.eimce.2021.01.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eimce.2021.01.007</ArticleId><ArticleId IdType="pmc">PMC9034266</ArticleId><ArticleId IdType="pubmed">35473989</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris AC, Hay AW, Swann DG, Everingham K, McCulloch C, McNulty J, Brooks O, Laurenson IF, Cook B, Walsh TS. Reducing ventilator-associated pneumonia in intensive care: impact of implementing a care bundle. Critical Care Medicine. 2011;39(10):2218–2224. doi: 10.1097/CCM.0b013e3182227d52.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e3182227d52</ArticleId><ArticleId IdType="pubmed">21666444</ArticleId></ArticleIdList></Reference><Reference><Citation>Motta I, Centis R, D’Ambrosio L, García-García JM, Goletti D, Gualano G, Lipani F, Palmieri F, Sánchez-Montalvá A, Pontali E, Sotgiu G, Spanevello A, Stochino C, Tabernero E, Tadolini M, van den Boom M, Villa S, Visca D, Migliori GB. Tuberculosis, COVID-19 and migrants: preliminary analysis of deaths occurring in 69 patients from two cohorts. Pulmonology. 2020;26(4):233–240. doi: 10.1016/j.pulmoe.2020.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pulmoe.2020.05.002</ArticleId><ArticleId IdType="pmc">PMC7221402</ArticleId><ArticleId IdType="pubmed">32411943</ArticleId></ArticleIdList></Reference><Reference><Citation>Mousquer GT, Peres A, Fiegenbaum M. Pathology of TB/COVID-19 co-infection: the phantom menace. Tuberculosis. 2021;126:102020. doi: 10.1016/j.tube.2020.102020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tube.2020.102020</ArticleId><ArticleId IdType="pmc">PMC7669479</ArticleId><ArticleId IdType="pubmed">33246269</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakagawara K, Kamata H, Chubachi S, Namkoong H, Tanaka H, Lee H, Otake S, Fukushima T, Kusumoto T, Morita A, Azekawa S, Watase M, Asakura T, Masaki K, Ishii M, Endo A, Koike R, Ishikura H, Takata T, Matsushita Y, Harada N, Kokutou H, Yoshiyama T, Kataoka K, Mutoh Y, Miyawaki M, Ueda S, Ono H, Ono T, Shoko T, Muranaka H, Kawamura K, Mori N, Mochimaru T, Fukui M, Chihara Y, Nagasaki Y, Okamoto M, Amishima M, Odani T, Tani M, Nishi K, Shirai Y, Edahiro R, Ando A, Hashimoto N, Ogura S, Kitagawa Y, Kita T, Kagaya T, Kimura Y, Miyazawa N, Tsuchida T, Fujitani S, Murakami K, Sano H, Sato Y, Tanino Y, Otsuki R, Mashimo S, Kuramochi M, Hosoda Y, Hasegawa Y, Ueda T, Takaku Y, Ishiguro T, Fujiwara A, Kuwahara N, Kitamura H, Hagiwara E, Nakamori Y, Saito F, Kono Y, Abe S, Ishii T, Ohba T, Kusaka Y, Watanabe H, Masuda M, Watanabe H, Kimizuka Y, Kawana A, Kasamatsu Y, Hashimoto S, Okada Y, Takano T, Katayama K, Ai M, Kumanogoh A, Sato T, Tokunaga K, Imoto S, Kitagawa Y, Kimura A, Miyano S, Hasegawa N, Ogawa S, Kanai T, Fukunaga K, Japan COVID-19 Task Force Diagnostic significance of secondary bacteremia in patients with COVID-19. Journal of Infection and Chemotherapy: Official Journal of the Japan Society of Chemotherapy. 2023;29(4):422–426. doi: 10.1016/j.jiac.2023.01.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiac.2023.01.006</ArticleId><ArticleId IdType="pmc">PMC9851919</ArticleId><ArticleId IdType="pubmed">36682606</ArticleId></ArticleIdList></Reference><Reference><Citation>Nebreda-Mayoral T, Miguel-Gómez MA, March-Rosselló GA, Puente-Fuertes L, Cantón-Benito E, Martínez-García AM, Muñoz-Martín AB, Orduña-Domingo A. Bacterial/fungal infection in hospitalized patients with COVID-19 in a tertiary hospital in the community of Castilla y León, Spain. Enfermedades infecciosas y microbiologia clinica (English ed.) 2022;40(4):158–165. doi: 10.1016/j.eimce.2022.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eimce.2022.02.002</ArticleId><ArticleId IdType="pmc">PMC8847094</ArticleId><ArticleId IdType="pubmed">35216948</ArticleId></ArticleIdList></Reference><Reference><Citation>Nori P, Cowman K, Chen V, Bartash R, Szymczak W, Madaline T, Punjabi Katiyar C, Jain R, Aldrich M, Weston G, Gialanella P, Corpuz M, Gendlina I, Guo Y. Bacterial and fungal coinfections in COVID-19 patients hospitalized during the New York City pandemic surge. Infection Control and Hospital Epidemiology. 2021;42(1):84–88. doi: 10.1017/ice.2020.368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/ice.2020.368</ArticleId><ArticleId IdType="pmc">PMC7417979</ArticleId><ArticleId IdType="pubmed">32703320</ArticleId></ArticleIdList></Reference><Reference><Citation>Palanisamy N, Vihari N, Meena DS, Kumar D, Midha N, Tak V, Sharma A, Bohra GK, Kothari N, Dutt N, Bhatia PK, Garg MK, Misra S. Clinical profile of bloodstream infections in COVID-19 patients: a retrospective cohort study. BMC Infectious Diseases. 2021;21(1):933. doi: 10.1186/s12879-021-06647-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-021-06647-x</ArticleId><ArticleId IdType="pmc">PMC8424166</ArticleId><ArticleId IdType="pubmed">34496787</ArticleId></ArticleIdList></Reference><Reference><Citation>Patton MJ, Orihuela CJ, Harrod KS, Bhuiyan MAN, Dominic P, Kevil CG, Fort D, Liu VX, Farhat M, Koff JL, Lal CV, Gaggar A, Richter RP, Erdmann N, Might M, Gaggar A. COVID-19 bacteremic co-infection is a major risk factor for mortality, ICU admission, and mechanical ventilation. Critical Care: The Official Journal of the Critical Care Forum. 2023;27:34. doi: 10.1186/s13054-023-04312-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-023-04312-0</ArticleId><ArticleId IdType="pmc">PMC9868503</ArticleId><ArticleId IdType="pubmed">36691080</ArticleId></ArticleIdList></Reference><Reference><Citation>Peddu V, Shean RC, Xie H, Shrestha L, Perchetti GA, Minot SS, Roychoudhury P, Huang ML, Nalla A, Reddy SB, Phung Q, Reinhardt A, Jerome KR, Greninger AL. Metagenomic analysis reveals clinical SARS-CoV-2 infection and bacterial or viral superinfection and colonization. Clinical Chemistry. 2020;66(7):966–972. doi: 10.1093/clinchem/hvaa106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinchem/hvaa106</ArticleId><ArticleId IdType="pmc">PMC7239240</ArticleId><ArticleId IdType="pubmed">32379863</ArticleId></ArticleIdList></Reference><Reference><Citation>Pijl JP, Londema M, Kwee TC, Nijsten M, Slart R, Dierckx R, van der Voort P, Glaudemans A, Pillay J. FDG-PET/CT in intensive care patients with bloodstream infection. Critical Care: The Official Journal of the Critical Care Forum. 2021;25:133. doi: 10.1186/s13054-021-03557-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-021-03557-x</ArticleId><ArticleId IdType="pmc">PMC8028784</ArticleId><ArticleId IdType="pubmed">33827655</ArticleId></ArticleIdList></Reference><Reference><Citation>Pourajam S, Kalantari E, Talebzadeh H, Mellali H, Sami R, Soltaninejad F, Amra B, Sajadi M, Alenaseri M, Kalantari F, Solgi H. Secondary bacterial infection and clinical characteristics in patients with COVID-19 admitted to two intensive care units of an academic hospital in Iran during the first wave of the pandemic. Frontiers in Cellular and Infection Microbiology. 2022;12:784130. doi: 10.3389/fcimb.2022.784130.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.784130</ArticleId><ArticleId IdType="pmc">PMC8904895</ArticleId><ArticleId IdType="pubmed">35281440</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad R, Patton MJ, Floyd JL, Fortmann S, DuPont M, Harbour A, Wright J, Lamendella R, Stevens BR, Oudit GY, Grant MB. Plasma microbiome in COVID-19 subjects: an indicator of gut barrier defects and dysbiosis. International Journal of Molecular Sciences. 2022;23(16):9141. doi: 10.3390/ijms23169141.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23169141</ArticleId><ArticleId IdType="pmc">PMC9409329</ArticleId><ArticleId IdType="pubmed">36012406</ArticleId></ArticleIdList></Reference><Reference><Citation>Rawson TM, Moore L, Zhu N, Ranganathan N, Skolimowska K, Gilchrist M, Satta G, Cooke G, Holmes A. Bacterial and fungal coinfection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 2020;71(9):2459–2468. doi: 10.1093/cid/ciaa530.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa530</ArticleId><ArticleId IdType="pmc">PMC7197596</ArticleId><ArticleId IdType="pubmed">32358954</ArticleId></ArticleIdList></Reference><Reference><Citation>Rawson TM, Wilson RC, Holmes A. Understanding the role of bacterial and fungal infection in COVID-19. Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. 2021;27:9–11. doi: 10.1016/j.cmi.2020.09.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.025</ArticleId><ArticleId IdType="pmc">PMC7546203</ArticleId><ArticleId IdType="pubmed">32979569</ArticleId></ArticleIdList></Reference><Reference><Citation>Razazi K, Arrestier R, Haudebourg AF, Benelli B, Carteaux G, Decousser JW, Fourati S, Woerther PL, Schlemmer F, Charles-Nelson A, Botterel F, de Prost N, Mekontso Dessap A. Risks of ventilator-associated pneumonia and invasive pulmonary aspergillosis in patients with viral acute respiratory distress syndrome related or not to Coronavirus 19 disease. Critical Care: The Official Journal of the Critical Care Forum. 2020;24:699. doi: 10.1186/s13054-020-03417-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03417-0</ArticleId><ArticleId IdType="pmc">PMC7747772</ArticleId><ArticleId IdType="pubmed">33339526</ArticleId></ArticleIdList></Reference><Reference><Citation>Razazi K, Martins Bexiga A, Arrestier R, Peiffer B, Voiriot G, Luyt CE, Urbina T, Mayaux J, Pham T, Roux D, Bellaiche R, AIt Hamou Z, Gaudry S, Azoulay E, Mekontso Dessap A, Rodriguez C, Pawlotsky JM, Fourati S, de Prost N. SARS-CoV-2 variants and mutational patterns: relationship with risk of ventilator-associated pneumonia in critically ill COVID-19 patients in the era of dexamethasone. Scientific Reports. 2023;13:6658. doi: 10.1038/s41598-023-33639-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-33639-5</ArticleId><ArticleId IdType="pmc">PMC10123590</ArticleId><ArticleId IdType="pubmed">37095145</ArticleId></ArticleIdList></Reference><Reference><Citation>Resar R, Pronovost P, Haraden C, Simmonds T, Rainey T, Nolan T. Using a bundle approach to improve ventilator care processes and reduce ventilator-associated pneumonia. Joint Commission Journal on Quality and Patient Safety. 2005;31(5):243–248. doi: 10.1016/S1553-7250(05)31031-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1553-7250(05)31031-2</ArticleId><ArticleId IdType="pubmed">15960014</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhee C, Dantes R, Epstein L, Murphy DJ, Seymour CW, Iwashyna TJ, Kadri SS, Angus DC, Danner RL, Fiore AE, Jernigan JA, Martin GS, Septimus E, Warren DK, Karcz A, Chan C, Menchaca JT, Wang R, Gruber S, Klompas M, CDC Prevention Epicenter Program Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009–2014. The Journal of the American Medical Association. 2017;318(13):1241–1249. doi: 10.1001/jama.2017.13836.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.13836</ArticleId><ArticleId IdType="pmc">PMC5710396</ArticleId><ArticleId IdType="pubmed">28903154</ArticleId></ArticleIdList></Reference><Reference><Citation>Rice LB. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. The Journal of Infectious Diseases. 2008;197(8):1079–1081. doi: 10.1086/533452.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/533452</ArticleId><ArticleId IdType="pubmed">18419525</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizvi SG, Ahammad SZ. COVID-19 and antimicrobial resistance: a cross-study. The Science of the Total Environment. 2022;807(Pt 2):150873. doi: 10.1016/j.scitotenv.2021.150873.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scitotenv.2021.150873</ArticleId><ArticleId IdType="pmc">PMC8500695</ArticleId><ArticleId IdType="pubmed">34634340</ArticleId></ArticleIdList></Reference><Reference><Citation>Rouzé A, Martin-Loeches I, Povoa P, Makris D, Artigas A, Bouchereau M, Lambiotte F, Metzelard M, Cuchet P, Boulle Geronimi C, Labruyere M, Tamion F, Nyunga M, Luyt CE, Labreuche J, Pouly O, Bardin J, Saade A, Asfar P, Baudel JL, Beurton A, Garot D, Ioannidou I, Kreitmann L, Llitjos JF, Magira E, Mégarbane B, Meguerditchian D, Moglia E, Mekontso-Dessap A, Reignier J, Turpin M, Pierre A, Plantefeve G, Vinsonneau C, Floch PE, Weiss N, Ceccato A, Torres A, Duhamel A, Nseir S, coVAPid study Group Relationship between SARS-CoV-2 infection and the incidence of ventilator-associated lower respiratory tract infections: a European multicenter cohort study. Intensive Care Medicine. 2021;47(2):188–198. doi: 10.1007/s00134-020-06323-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-06323-9</ArticleId><ArticleId IdType="pmc">PMC7778569</ArticleId><ArticleId IdType="pubmed">33388794</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruuskanen O, Lahti E, Jennings LC, Murdoch DR. Viral pneumonia. Lancet. 2011;377(9773):1264–1275. doi: 10.1016/S0140-6736(10)61459-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61459-6</ArticleId><ArticleId IdType="pmc">PMC7138033</ArticleId><ArticleId IdType="pubmed">21435708</ArticleId></ArticleIdList></Reference><Reference><Citation>Saini V, Jain C, Singh NP, Alsulimani A, Gupta C, Dar SA, Haque S, Das S. Paradigm shift in antimicrobial resistance pattern of bacterial isolates during the COVID-19 pandemic. Antibiotics. 2021;10(8):954. doi: 10.3390/antibiotics10080954.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antibiotics10080954</ArticleId><ArticleId IdType="pmc">PMC8388877</ArticleId><ArticleId IdType="pubmed">34439004</ArticleId></ArticleIdList></Reference><Reference><Citation>Salehi M, Ahmadikia K, Mahmoudi S, Kalantari S, Jamalimoghadamsiahkali S, Izadi A, Kord M, Dehghan Manshadi SA, Seifi A, Ghiasvand F, Khajavirad N, Ebrahimi S, Koohfar A, Boekhout T, Khodavaisy S. Oropharyngeal candidiasis in hospitalised COVID-19 patients from Iran: species identification and antifungal susceptibility pattern. Mycoses. 2020;63(8):771–778. doi: 10.1111/myc.13137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/myc.13137</ArticleId><ArticleId IdType="pmc">PMC7361944</ArticleId><ArticleId IdType="pubmed">32609906</ArticleId></ArticleIdList></Reference><Reference><Citation>Sang L, Xi Y, Lin Z, Pan Y, Song B, Li CA, Zheng X, Zhong M, Jiang L, Pan C, Zhang W, Lv Z, Xia J, Chen N, Wu W, Xu Y, Chen S, Liu D, Liang W, Liu X, Liu X, Li S, Zhong N, Ye D, Xu Y, Zhang N, Zhang D, Li Y. Secondary infection in severe and critical COVID-19 patients in China: a multicenter retrospective study. Annals of Palliative Medicine. 2021;10(8):8557–8570. doi: 10.21037/apm-21-833.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/apm-21-833</ArticleId><ArticleId IdType="pubmed">34379989</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkar S, Khanna P, Singh AK. Impact of COVID-19 in patients with concurrent co-infections: a systematic review and meta-analyses. Journal of Medical Virology. 2021;93(4):2385–2395. doi: 10.1002/jmv.26740.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26740</ArticleId><ArticleId IdType="pubmed">33331656</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah T, Shah Z, Yasmeen N, Baloch Z, Xia X. Pathogenesis of SARS-CoV-2 and Mycobacterium tuberculosis coinfection. Frontiers in Immunology. 2022;13:909011. doi: 10.3389/fimmu.2022.909011.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.909011</ArticleId><ArticleId IdType="pmc">PMC9246416</ArticleId><ArticleId IdType="pubmed">35784278</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharifipour E, Shams S, Esmkhani M, Khodadadi J, Fotouhi-Ardakani R, Koohpaei A, Doosti Z, Ej Golzari S. Evaluation of bacterial co-infections of the respiratory tract in COVID-19 patients admitted to ICU. BMC Infectious Diseases. 2020;20:646. doi: 10.1186/s12879-020-05374-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-020-05374-z</ArticleId><ArticleId IdType="pmc">PMC7461753</ArticleId><ArticleId IdType="pubmed">32873235</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen Z, Xiao Y, Kang L, Ma W, Shi L, Zhang L, Zhou Z, Yang J, Zhong J, Yang D, Guo L, Zhang G, Li H, Xu Y, Chen M, Gao Z, Wang J, Ren L, Li M. Genomic diversity of severe acute respiratory syndrome-coronavirus 2 in patients with coronavirus disease 2019. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 2020;71(15):713–720. doi: 10.1093/cid/ciaa203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa203</ArticleId><ArticleId IdType="pmc">PMC7108196</ArticleId><ArticleId IdType="pubmed">32129843</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi H, Han X, Jiang N, Cao Y, Alwalid O, Gu J, Fan Y, Zheng C. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. The Lancet. Infectious Diseases. 2020;20(4):425–434. doi: 10.1016/S1473-3099(20)30086-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30086-4</ArticleId><ArticleId IdType="pmc">PMC7159053</ArticleId><ArticleId IdType="pubmed">32105637</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC. The third international consensus definitions for sepsis and septic shock (Sepsis-3) The Journal of the American Medical Association. 2016;315(8):801–810. doi: 10.1001/jama.2016.0287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0287</ArticleId><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano MC, Vaquero C, Ortiz-Fernández A, Caballero A, Blandino-Ortiz A, de Pablo R. Low incidence of co-infection, but high incidence of ICU-acquired infections in critically ill patients with COVID-19. The Journal of Infection. 2021;82(2):e20–20e21. doi: 10.1016/j.jinf.2020.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.09.010</ArticleId><ArticleId IdType="pmc">PMC7501527</ArticleId><ArticleId IdType="pubmed">32956729</ArticleId></ArticleIdList></Reference><Reference><Citation>Strålin K, Wahlström E, Walther S, Bennet-Bark AM, Heurgren M, Lindén T, Holm J, Hanberger H. Mortality trends among hospitalised COVID-19 patients in Sweden: a nationwide observational cohort study. The Lancet. Regional Health-Europe. 2021;4(11):100054. doi: 10.1016/j.lanepe.2021.100054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100054</ArticleId><ArticleId IdType="pmc">PMC7907732</ArticleId><ArticleId IdType="pubmed">33997829</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinbeis F, Thibeault C, Doellinger F, Ring RM, Mittermaier M, Ruwwe-Glösenkamp C, Alius F, Knape P, Meyer HJ, Lippert LJ, Helbig ET, Grund D, Temmesfeld-Wollbrück B, Suttorp N, Sander LE, Kurth F, Penzkofer T, Witzenrath M, Zoller T. Severity of respiratory failure and computed chest tomography in acute COVID-19 correlates with pulmonary function and respiratory symptoms after infection with SARS-CoV-2: an observational longitudinal study over 12 months. Respiratory Medicine. 2022;191(8):106709. doi: 10.1016/j.rmed.2021.106709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2021.106709</ArticleId><ArticleId IdType="pmc">PMC8632363</ArticleId><ArticleId IdType="pubmed">34871947</ArticleId></ArticleIdList></Reference><Reference><Citation>Strelkova D, Rachina S, Fedina L, Vlasenko A, Tetevina M, Drogashevskaya D, Chesnokova M, Kuleshov V, Burmistrova E, Sychev I, Ananicheva N. Identification of risk factors and development of a predictive model for bloodstream infection in intensive care unit COVID-19 patients. The Journal of Hospital Infection. 2023;139(2):150–157. doi: 10.1016/j.jhin.2023.06.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhin.2023.06.026</ArticleId><ArticleId IdType="pubmed">37478910</ArticleId></ArticleIdList></Reference><Reference><Citation>Subedi D, Vijay AK, Willcox M. Overview of mechanisms of antibiotic resistance in Pseudomonas aeruginosa: an ocular perspective. Clinical &amp; Experimental Optometry. 2018;101(2):162–171. doi: 10.1111/cxo.12621.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cxo.12621</ArticleId><ArticleId IdType="pubmed">29044738</ArticleId></ArticleIdList></Reference><Reference><Citation>Sulayyim H, Ismail R, Hamid AA, Ghafar NA. Antibiotic resistance during COVID-19: a systematic review. International Journal of Environmental Research and Public Health. 2022;19(19):11931. doi: 10.3390/ijerph191911931.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph191911931</ArticleId><ArticleId IdType="pmc">PMC9565540</ArticleId><ArticleId IdType="pubmed">36231256</ArticleId></ArticleIdList></Reference><Reference><Citation>Sy K, Haw N, Uy J. Previous and active tuberculosis increases risk of death and prolongs recovery in patients with COVID-19. Infectious Diseases. 2020;52(12):902–907. doi: 10.1080/23744235.2020.1806353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2020.1806353</ArticleId><ArticleId IdType="pubmed">32808838</ArticleId></ArticleIdList></Reference><Reference><Citation>Tadolini M, Codecasa LR, García-García JM, Blanc FX, Borisov S, Alffenaar JW, Andréjak C, Bachez P, Bart PA, Belilovski E, Cardoso-Landivar J, Centis R, D’Ambrosio L, Luiza De Souza-Galvão M, Dominguez-Castellano A, Dourmane S, Fréchet Jachym M, Froissart A, Giacomet V, Goletti D, Grard S, Gualano G, Izadifar A, Le Du D, Marín Royo M, Mazza-Stalder J, Motta I, Ong C, Palmieri F, Rivière F, Rodrigo T, Silva DR, Sánchez-Montalvá A, Saporiti M, Scarpellini P, Schlemmer F, Spanevello A, Sumarokova E, Tabernero E, Tambyah PA, Tiberi S, Torre A, Visca D, Zabaleta Murguiondo M, Sotgiu G, Migliori GB. Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases. The European Respiratory Journal. 2020;56:2001398. doi: 10.1183/13993003.01398-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01398-2020</ArticleId><ArticleId IdType="pmc">PMC7251245</ArticleId><ArticleId IdType="pubmed">32457198</ArticleId></ArticleIdList></Reference><Reference><Citation>TB/COVID-19 Global Study Group Tuberculosis and COVID-19 co-infection: description of the global cohort. The European Respiratory Journal. 2022;59(3):2102538. doi: 10.1183/13993003.02538-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02538-2021</ArticleId><ArticleId IdType="pmc">PMC8588566</ArticleId><ArticleId IdType="pubmed">34764184</ArticleId></ArticleIdList></Reference><Reference><Citation>Temperoni C, Caiazzo L, Barchiesi F. High prevalence of antibiotic resistance among opportunistic pathogens isolated from patients with COVID-19 under mechanical ventilation: results of a single-center study. Antibiotics. 2021;10(9):1080. doi: 10.3390/antibiotics10091080.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antibiotics10091080</ArticleId><ArticleId IdType="pmc">PMC8467890</ArticleId><ArticleId IdType="pubmed">34572662</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiri B, Sensi E, Marsiliani V, Cantarini M, Priante G, Vernelli C, Martella LA, Costantini M, Mariottini A, Andreani P, Bruzzone P, Suadoni F, Francucci M, Cirocchi R, Cappanera S. Antimicrobial stewardship program, COVID-19, and infection control: spread of carbapenem-resistant klebsiella pneumoniae colonization in ICU COVID-19 patients. What did not work? Journal of Clinical Medicine. 2020;9(9):2744. doi: 10.3390/jcm9092744.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9092744</ArticleId><ArticleId IdType="pmc">PMC7563368</ArticleId><ArticleId IdType="pubmed">32854334</ArticleId></ArticleIdList></Reference><Reference><Citation>Torrecillas M, Gumucio VD, Padullés A, Tubau F, Marco D, Shaw E, Fernández-Huerta M, Maisterra K, Grau I, Petito MM, Berbel D, Puig-Asensio M, Pérez XL, Domínguez MÁ, Sabater J, Ardanuy C, Càmara J. Antimicrobial use and aetiology of bloodstream infections in critically ill patients during early stages of SARS-CoV-2 pandemic. Infection Prevention in Practice. 2022;4(4):100241. doi: 10.1016/j.infpip.2022.100241.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.infpip.2022.100241</ArticleId><ArticleId IdType="pmc">PMC9420204</ArticleId><ArticleId IdType="pubmed">36061570</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres-Castro R, Vasconcello-Castillo L, Alsina-Restoy X, Solis-Navarro L, Burgos F, Puppo H, Vilaró J. Respiratory function in patients post-infection by COVID-19: a systematic review and meta-analysis. Pulmonology. 2021;27(4):328–337. doi: 10.1016/j.pulmoe.2020.10.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pulmoe.2020.10.013</ArticleId><ArticleId IdType="pmc">PMC7687368</ArticleId><ArticleId IdType="pubmed">33262076</ArticleId></ArticleIdList></Reference><Reference><Citation>US Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases  COVID-19: U.S. Impact on antimicrobial resistance, special report 2022. 2022. https://stacks.cdc.gov/view/cdc/117915 https://stacks.cdc.gov/view/cdc/117915</Citation></Reference><Reference><Citation>Vail EA, Gershengorn HB, Wunsch H, Walkey AJ. Attention to immortal time bias in critical care research. American Journal of Respiratory and Critical Care Medicine. 2021;203(10):1222–1229. doi: 10.1164/rccm.202008-3238CP.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202008-3238CP</ArticleId><ArticleId IdType="pubmed">33761299</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkataraman T, Frieman MB. The role of epidermal growth factor receptor (EGFR) signaling in SARS coronavirus-induced pulmonary fibrosis. Antiviral Research. 2017;143(3):142–150. doi: 10.1016/j.antiviral.2017.03.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2017.03.022</ArticleId><ArticleId IdType="pmc">PMC5507769</ArticleId><ArticleId IdType="pubmed">28390872</ArticleId></ArticleIdList></Reference><Reference><Citation>Viana R, Moyo S, Amoako DG, Tegally H, Scheepers C, Althaus CL, Anyaneji UJ, Bester PA, Boni MF, Chand M, Choga WT, Colquhoun R, Davids M, Deforche K, Doolabh D, du Plessis L, Engelbrecht S, Everatt J, Giandhari J, Giovanetti M, Hardie D, Hill V, Hsiao NY, Iranzadeh A, Ismail A, Joseph C, Joseph R, Koopile L, Kosakovsky Pond SL, Kraemer M, Kuate-Lere L, Laguda-Akingba O, Lesetedi-Mafoko O, Lessells RJ, Lockman S, Lucaci AG, Maharaj A, Mahlangu B, Maponga T, Mahlakwane K, Makatini Z, Marais G, Maruapula D, Masupu K, Matshaba M, Mayaphi S, Mbhele N, Mbulawa MB, Mendes A, Mlisana K, Mnguni A, Mohale T, Moir M, Moruisi K, Mosepele M, Motsatsi G, Motswaledi MS, Mphoyakgosi T, Msomi N, Mwangi PN, Naidoo Y, Ntuli N, Nyaga M, Olubayo L, Pillay S, Radibe B, Ramphal Y, Ramphal U, San JE, Scott L, Shapiro R, Singh L, Smith-Lawrence P, Stevens W, Strydom A, Subramoney K, Tebeila N, Tshiabuila D, Tsui J, van Wyk S, Weaver S, Wibmer CK, Wilkinson E, Wolter N, Zarebski AE, Zuze B, Goedhals D, Preiser W, Treurnicht F, Venter M, Williamson C, Pybus OG, Bhiman J, Glass A, Martin DP, Rambaut A, Gaseitsiwe S, von Gottberg A, de Oliveira T. Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa. Nature. 2022;603(7902):679–686. doi: 10.1038/s41586-022-04411-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04411-y</ArticleId><ArticleId IdType="pmc">PMC8942855</ArticleId><ArticleId IdType="pubmed">35042229</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, Moreno R, Lipman J, Gomersall C, Sakr Y, Reinhart K, EPIC II Group of Investigators International study of the prevalence and outcomes of infection in intensive care units. The Journal of the American Medical Association. 2009;302(21):2323–2329. doi: 10.1001/jama.2009.1754.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2009.1754</ArticleId><ArticleId IdType="pubmed">19952319</ArticleId></ArticleIdList></Reference><Reference><Citation>Visca D, Ong C, Tiberi S, Centis R, D’Ambrosio L, Chen B, Mueller J, Mueller P, Duarte R, Dalcolmo M, Sotgiu G, Migliori GB, Goletti D. Tuberculosis and COVID-19 interaction: a review of biological, clinical and public health effects. Pulmonology. 2021;27(2):151–165. doi: 10.1016/j.pulmoe.2020.12.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pulmoe.2020.12.012</ArticleId><ArticleId IdType="pmc">PMC7825946</ArticleId><ArticleId IdType="pubmed">33547029</ArticleId></ArticleIdList></Reference><Reference><Citation>Wardoyo EH, Suardana IW, Yasa I, Sukrama I. Antibiotics susceptibility of Escherichia coli isolates from clinical specimens before and during COVID-19 pandemic. Iranian Journal of Microbiology. 2021;13(2):156–160. doi: 10.18502/ijm.v13i2.5974.</Citation><ArticleIdList><ArticleId IdType="doi">10.18502/ijm.v13i2.5974</ArticleId><ArticleId IdType="pmc">PMC8408029</ArticleId><ArticleId IdType="pubmed">34540149</ArticleId></ArticleIdList></Reference><Reference><Citation>Wendisch D, Dietrich O, Mari T, von Stillfried S, Ibarra IL, Mittermaier M, Mache C, Chua RL, Knoll R, Timm S, Brumhard S, Krammer T, Zauber H, Hiller AL, Pascual-Reguant A, Mothes R, Bülow RD, Schulze J, Leipold AM, Djudjaj S, Erhard F, Geffers R, Pott F, Kazmierski J, Radke J, Pergantis P, Baßler K, Conrad C, Aschenbrenner AC, Sawitzki B, Landthaler M, Wyler E, Horst D, Deutsche COVID-19 OMICS Initiative (DeCOI) Hippenstiel S, Hocke A, Heppner FL, Uhrig A, Garcia C, Machleidt F, Herold S, Elezkurtaj S, Thibeault C, Witzenrath M, Cochain C, Suttorp N, Drosten C, Goffinet C, Kurth F, Schultze JL, Radbruch H, Ochs M, Eils R, Müller-Redetzky H, Hauser AE, Luecken MD, Theis FJ, Conrad C, Wolff T, Boor P, Selbach M, Saliba AE, Sander LE. SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis. Cell. 2021;184(26):6243–6261.e27. doi: 10.1016/j.cell.2021.11.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.11.033</ArticleId><ArticleId IdType="pmc">PMC8626230</ArticleId><ArticleId IdType="pubmed">34914922</ArticleId></ArticleIdList></Reference><Reference><Citation>Westblade LF, Simon MS, Satlin MJ. Bacterial coinfections in coronavirus disease 2019. Trends in Microbiology. 2021;29(10):930–941. doi: 10.1016/j.tim.2021.03.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2021.03.018</ArticleId><ArticleId IdType="pmc">PMC8026275</ArticleId><ArticleId IdType="pubmed">33934980</ArticleId></ArticleIdList></Reference><Reference><Citation>Wicky PH, Niedermann MS, Timsit JF. Ventilator-associated pneumonia in the era of COVID-19 pandemic: how common and what is the impact. Critical Care: The Official Journal of the Critical Care Forum. 2021;25(1):153. doi: 10.1186/s13054-021-03571-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-021-03571-z</ArticleId><ArticleId IdType="pmc">PMC8059113</ArticleId><ArticleId IdType="pubmed">33882991</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization  Antibiotic resistance. 2021. https://www.who.int/news-room/fact-sheets/detail/antibiotic-resistance. https://www.who.int/news-room/fact-sheets/detail/antibiotic-resistance (accessed 20 September 2021)</Citation></Reference><Reference><Citation>Wu HY, Chang PH, Chen KY, Lin IF, Hsih WH, Tsai WL, Chen JA, Lee SS, GREAT Working Group Coronavirus disease 2019 (COVID-19) associated bacterial coinfection: incidence, diagnosis and treatment. Journal of Microbiology, Immunology, and Infection. 2022;55(6 Pt 1):985–992. doi: 10.1016/j.jmii.2022.09.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2022.09.006</ArticleId><ArticleId IdType="pmc">PMC9536868</ArticleId><ArticleId IdType="pubmed">36243668</ArticleId></ArticleIdList></Reference><Reference><Citation>Zahariadis G, Gooley TA, Ryall P, Hutchinson C, Latchford MI, Fearon MA, Jamieson FB, Richardson S, Kuschak T, Mederski B. Risk of ruling out severe acute respiratory syndrome by ruling in another diagnosis: variable incidence of atypical bacteria coinfection based on diagnostic assays. Canadian Respiratory Journal. 2006;13(1):17–22. doi: 10.1155/2006/862797.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2006/862797</ArticleId><ArticleId IdType="pmc">PMC2539008</ArticleId><ArticleId IdType="pubmed">16470249</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang G, Hu C, Luo L, Fang F, Chen Y, Li J, Peng Z, Pan H. Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China. Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology. 2020;127:104364. doi: 10.1016/j.jcv.2020.104364.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2020.104364</ArticleId><ArticleId IdType="pmc">PMC7194884</ArticleId><ArticleId IdType="pubmed">32311650</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. doi: 10.1016/S0140-6736(20)30566-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T, Zhan H, Zhang F, Liu Q, Tso E, Lui G, Chen N, Li A, Lu W, Chan F, Chan P, Ng SC. Alterations in fecal fungal microbiome of patients with COVID-19 during time of hospitalization until discharge. Gastroenterology. 2020;159(4):1302–1310.e5. doi: 10.1053/j.gastro.2020.06.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.06.048</ArticleId><ArticleId IdType="pmc">PMC7318920</ArticleId><ArticleId IdType="pubmed">32598884</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>